Antibacterial and antibiofilm activity of selected polyphenolic compounds: An in vitro study on Staphylococcus aureus by Kostić, Marina***marina.kostic@ibiss.bg.ac.rs****** et al.
Research Article Natural Medicinal Materials vol. 40 (2020) 57
Antibacterial and antibiofilm activity of selected
polyphenolic compounds: An in vitro study on
Staphylococcus aureus
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Staphylococcus aureus is a human pathogen that causes serious infections with high mortality rates.
The antimicrobial activities of eight phenolic compounds (caffeic acid, chlorogenic acid, ferulic acid,
morin, quercetin, isoquercitrin, rutin and hesperidin) were evaluated against planktonic and biofilm
forming Staphylococcus aureus cells. Their ability to prevent biofilm formation via interference with
bacterial cell adhesion and to reduce biomass of 24 h old biofilms has been addressed in this study.
The antibacterial activities (MIC/MBC) were demonstrated using the microdilution method and the
investigated compounds showed good activity against S. aureus isolates, with MICs in the range 0.05-
0.4 mg/mL. Also, they exhibited promising antibiofilm potential in dose depended manner. Among
all tested compounds, morin and quercetin showed the best antibiofilm activity at MIC values. The
observed antimicrobial potential of the studied natural products can serve as a starting point towards
development of novel plant-based therapeutics for the treatment of common infections such as the
ones caused by S. aureus.
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1. INTRODUCTION
Staphylococcus aureus is an opportunistic pathogen frequently
linked to skin and soft-tissue infections, osteomyelitis, sep-
tic arthritis, chronic sinusitis and tonsillitis (Chalmers and
Wylam, 2020; Kostić et al., 2020a). In the case of bloodstream
infection caused by this bacterium there is a serious concern
due to high mortality rates: in the United States among 120000
S. aureus bloodstream infections recorded in 2017, 20000 were
with death outcome (Kourtis et al., 2019). Chronic and per-
sistent infections by this microorganism are correlated with
its ability to establish biofilms (Figueiredo et al., 2017) – trait
that is directly linked to antimicrobial resistance (Manand-
har et al., 2018). Resistance of biofilms is caused by lower
ability of drugs to penetrate through biofilm matrix and differ-
ent physiology of biofilm cell compared to the cells grow-
ing in planktonic phase (Craft et al., 2019). Biofilms can
be established on indwelling medical devices; including im-
planted artificial heart valves, catheters and joint prosthetics
and these usually lead to increased duration of patients hospi-
tal stay. The process of biofilm formation starts by attachment
of cells on the surface, while next phases include accumula-
tion/maturation and subsequent detachment and dispersal
of mature biofilms (Moormeier and Bayles, 2017). The main
constituents of biofilm matrix include oligosaccharides, DNA,
proteins and teichoic acids while a cyclic peptide, autoinduc-
ing peptide, serves as a messenger in the intercellular bacte-
rial communication during biofilm establishment (Craft et al.,
2019). Recent studies have highlighted the potential of dif-
ferent agents against S. aureus biofilms including mushrooms
(Kostić et al., 2020b), fruit peel (Stojković et al., 2018), acidic
amino acids (Warraich et al., 2020) and essential oils (Kerekes
et al., 2019), but the search for efficient antibiofilm therapeutics
is still running.
Compounds of natural origin have been seen as an attrac-
tive source of novel anti-quorum sensing agents including the
ones with antibiofilm activities (Ćirić et al., 2020). Phenolic
compounds are all over distributed phytochemicals found
in majority of plant organs and tissues, including vegetables
and fruits. They are specialized metabolites which biosyn-
thesis goes through the phenylpropanoid and shikimic acid
pathways. These compounds possess numerous bioactivities
and, although they are not nutrients, dietary intake provides
health-protective effects. Besides antioxidant activity, as one
of the most studied bioactivities of phenolic compounds, an-
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timicrobial potential has also been explored (Smiljkovic et al.,
2017; Stojković et al., 2013). However, their antibiofilm poten-
tial is in much lower proportion revealed compared to their
antimicrobial effect towards planktonic cells (Smiljković et al.,
2019).
Some recent studies (Ivanov et al., 2020; Slobodníková et al.,
2016) highlighted a significant antibiofilm potential existing
among the molecules from this group - a feature deserving
more detailed experiments. This study aimed to further en-
lighten potential antimicrobial and antibiofilm role of selected
phenolic compounds, caffeic acid, chlorogenic acid, ferulic
acid, morin, quercetin, isoquercitrin, rutin and hesperidin to-
wards Staphylococcus aureus as bacterial model system for
the study.
2. MATERIALS AND METHODS
2.1. Compounds collection
The following compounds were purchased from Extrasyn-
these (GenayCedex, France): caffeic acid, chlorogenic acid, fer-
ulic acid, morin, quercetin, isoquercitrin, rutin and hesperidin.
The selected antibiotic amoxicillin with clavulanic acid was
purchased from Hemofarm (Vršac, Serbia). The phenolic com-
pounds were dissolved in 30 % ethanol, and antibiotic was
dissolved in sterile water in concentration 1 mg/mL.
2.2. Microorganisms
Two S. aureus strains (clinical isolate and ATCC 11632) were
used. Clinical isolate was obtained from palatine tonsil of a
patient after obtaining informed written consent, at Otorhi-
nolaryngology clinic at Clinical Hospital Center Zvezdara,
Belgrade, Serbia.The species were maintained in Triptone Soy
Agar (TSA, Torlak, Serbia). The microorganisms are deposited
at the Mycological Laboratory, Department of Plant Physi-
ology, Institute for Biological Research “Siniša Stanković”,
Belgrade, Serbia.
2.3. Antibacterial susceptibility test
Microdilution method with some modifications (Kostić et al.,
2017) was used to examine antibacterial activity of selected
phenolic compounds. MICs were observed as the lowest con-
centrations with no visible bacterial growth. MBCs were deter-
mined by serial sub-cultivation of 10 µL into microtiter plates
containing 100 µL of broth per well and further incubation
at 37 °C for 24 h. The lowest concentration with no visible
growth was defined as MBC. All experiments were repeated
two times.
2.4. Inhibition of biofilm formation
The ability of phenolic compounds to inhibit biofilm formation
was determined as described previously with some modifi-
cations (Kostić et al., 2020b). S. aureus cells were incubated
in 96 well microtiter plates with adhesive bottom (Sarstedt,
Germany) with MIC and sub-MIC concentrations of tested
phenolic compounds at 37 °C for 24 hours. Then, wells were
washed twice with sterile PBS (Phosphate buffered saline,
pH 7.4), and biofilms were fixed with methanol for 10 min;
next, methanol was removed and the plate was air dried and
stained with 0.1 % crystal violet (Bio-Merieux, France) for 30
min. Wells were washed with water, air dried and 100 µL of
96 % ethanol (Zorka, Serbia) was added to dissolve bound
crystal violet. The absorbance was read at 570 nm using a
plate reader. The percentage of inhibition of biofilm formation
was calculated by the formula:
Inhibition (%) =
Acontrol − Asample
Acontrol
× 100
2.5. Inhibition of formed biofilm
Potential of selected phenolic compounds to disturb estab-
lished biofilms was determined according to Smiljković et al.
(2018). Strains of S. aureus were grown in Triptic soy broth
enriched with 2 % glucose in microtiter plates with adhesive
bottom for 24 h at 37 °C. Wells were washed twice and the
remaining biofilm was treated with tested compounds for 60 s
at MBC values. The wells were washed; the remaining biofilm
was fixed with methanol and after air drying, it was stained
with 0.1 % crystal violet. After dissolving the stain in ethanol,
the absorbance was read and the percentage of destruction of
already formed biofilm was calculated as mentioned above.
Table 1. Minimal inhibitory (MIC) and minimal bactericidal
concentrations (MFC) of phenolic compounds (mg/mL) against
two Staphylococcus aureus isolates.
Compound Clinical isolate ATCC 11632
MIC MBC MIC MBC
caffeic acid 0.4 0.4 0.1 0.2
chlorogenic acid 0.4 0.4 0.2 0.4
ferulic acid 0.4 0.4 0.2 0.4
morin 0.2 0.4 0.05 0.2
quercetin 0.2 0.4 0.2 0.4
isoquercitrin 0.2 0.4 0.1 0.2
rutin 0.4 0.8 0.2 0.4
hesperidin 0.4 0.4 0.2 0.4
amox./clav. acida 0.001 0.002 0.001 0.002
a Amoxicillin and clavulanic acid are commercial antibiotics used as positive
control
3. RESULTS AND DISCUSSION
Antibacterial activities of eight tested phenolic compounds
against two strains of the S. aureus, are presented in Table 1.
The antibacterial activity was in the range of 0.05–0.4 mg/mL
for inhibitory activity (MIC values), and 0.1–0.8 mg/mL for
bactericidal activity (MBC). S. aureus ATCC 11632 was more
susceptible to the application of examined phenolic com-
pounds compared to S. aureus clinical isolate, MIC in range
0.05-0.2 mg/mL and 0.1-0.4 mg/mL, respectively. Morin, caf-
feic acid and isoquercitrin showed the best activity against
S. aureus ATCC 11632 (MIC values 0.05-0.1 mg/mL). Against
S. aureus clinical isolate morin, quercetin and isoquercitrin
were the compounds with the best activity (MIC value 0.2
mg/mL). Commercially available antibiotic amoxicillin with
clavulanic acid proved to be more effective against S. aureus
isolates than the phenolic compounds, but considering its side
effects and raising antimicrobial resitanceresistance among
pathogens the activity of naturally bioactive compounds is of
great importance. In the past few years, there are several re-
ports regarding antibacterial activity of caffeic acid (dos Santos
et al., 2018; Lima et al., 2016; Kępa et al., 2018), chlorogenic acid
(Adamczak et al., 2019; Li et al., 2014; Wang et al., 2015), fer-
ulic acid (Borges et al., 2012; 2013;), morin (Gutiérrez-Venegas
et al., 2019), quecetrin (Adamczak et al., 2019; da Costa Júnior
et al., 2018; Gutiérrez-Venegas et al., 2019), hesperidin (Lopes
et al., 2017), and rutin (Gutiérrez-Venegas et al., 2019) against
S. aureus different strains (Table 2).
Biofilm results indicated that among eight tested phenolic com-
pounds, ferulic acid, morin, quercetin, and hesperidin inhibit
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Table 2. Previously reported minimal inhibitory concentrations (MIC) of selected phenolic compounds against different Staphylo-
coccus aureus isolates
Compound Isolate MIC Reference
[mg/mL]
caffeic acid Clinical isolate ≥1.024 Li et al. (2014)
ATCC 25923, ATCC 43300, ATCC 6538 0.256 Kępa et al. (2018)
RN4220, 1199B >1.024 dos Santos et al. (2018)
chlorogenic acid ATCC 29213 2.56 Li et al. (2014)
ATCC 25904, ATCC 25923, ATCC 29213 >1.024 Wang et al. (2015)
unknown 1.000 Adamczak et al. (2019)
ferulic acid CECT 976 1.100 Borges et al. (2013; 2012)
morin ATCC 25923 1.000 Gutiérrez-Venegas et al. (2019)
quercetin Clinical isolates, ATCC 29213, ATCC 33591 0.001 – >0.256 da Costa Júnior et al. (2018)
ATCC 25923 0.050 Gutiérrez-Venegas et al. (2019)
unknown > 1.000 Adamczak et al. (2019)
hesperidin RN4220, SA1199B >1.024 Lopes et al. (2017)
rutin ATCC 25923 1.000 Gutiérrez-Venegas et al. (2019)
Fig. 1. Inhibition of S. aureus (clinical isolate) and S. aureus ATCC
11632 biofilm formation by phenolic compounds (%).
S. aureus (clinical isolate) cell attachment for above the 60 % at
MIC value, while for S. aureus ATCC 11623, only hesperidin
showed inhibition of biofilm formation above 60 % (Figure 1).
Among the tested compounds, caffeic acid showed the lowest
antibiofilm activity with an inhibition value of 7.50 % (for S.
aureus ATCC 11632) and isoquercitrin with 39 % (for S. aureus
clinical isolate). Isoquercitrin didn’t exhibit antibiofilm activ-
ity towards S. aureus clinical isolate at sub-MIC value. Morin
and rutin are two compounds which didn’t show antibiofilm
activity towards S. aureus ATCC 11632. Caffeic, chlorogenic,
ferulic acids and morin, rutin and hesperidin didn’t exhibit
antibiofilm effect on S. aureus ATCC strain at sub-MIC (Figure
1). The effect of the 60 s treatment with different phenolic
compounds on S. aureus established biofilms was tested. All
examined compounds exhibited demolishing activity against
established biofilms (Figure 2). The best activity was accom-
plished by hesperidin- its application has reduced established
biofilm biomass of S. aureus clinical isolate for 74 %, while
quercetin demolished S. aureus ATCC 11632 biofilm for 57 %.
Fig. 2. Destruction of 24 h old S. aureus (clinical isolate and ATCC
11632) biofilms after 60 s treatment with MBC of phenolic com-
pounds (%).
Isoquercetrin showed the lowest activity among the tested
natural products. According to Cho et al. (2015), quercetin
at 0.05 mg/mL significantly inhibits biofilm production of S.
aureus ATCC 6538 strain after 24 h while in our study con-
centration of 0.2 mg/mL quercetrin was necessary for biofilm
reduction. Abreu et al. (2016) demonstrated effect of the morin
and quercetin in biofilm prevention, when they were applied
alone or in combination with antibiotics. Morin (500 mg/L)
applied for 1 h caused highest CFU reduction (1.2-2.1 CFU
cm2) then quecetrin and antibiotics, but after 24 h, both morin
and quercetin showed activity in preventing biofilm formation
of SA1199B and XU212 strains. In the combination, tetracy-
cline combined with pyrrolidine and morin showed promising
effect against XU212 strain.
Phenolic acids have shown the similar behaviour in mi-
crodilution test against free floating cells and against mi-
crobial biofilm. It could be presumed that glycosylation of
flavonoids (quercetin as aglycon) contributes to the lower ac-
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tivity recorded in the tests of antibiofilm activity. However,
glycosylation of flavonoids seemed to have better or no ef-
fect on MICs than aglycone forms, depending on substitution
position of sugars, as shown by the results of microdilution
method. According to Méndez and Salas (2001) and Hyung Ko
et al. (2006), sugar ligands can mediate drug targeting and bi-
ological activity. Overall, glycosylated molecules were less
active against microbial biofilms, and their activity seemed to
be time dependant. Overall, all of the phenolic compounds
expressed the activities investigated in the current study. It
seems that antimicrobial potential of phenolic acids versus
flavonoids was subordinated to chemical structures of indi-
vidual compounds.
CONCLUSION
The results obtained in this work indicate that phenolic com-
pounds, particulary morin possess promising antibacterial
activity. Furthermore, all tested compounds exhibited promis-
ing antibiofilm potential in both assays - feature especially
accomplished by quercetin and morin. The observed antimi-
crobial and antibiofilm potential of phenolic compounds can
serve as one step more towards the development of novel
treatment for the S. aureus infections.
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